Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.

Vanderbilt investigators have discovered a new type of immune cell residing in the intestinal epithelium that may function as a first line of defense against ingested pathogens.

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.

Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses?